NEUROCRINE BIOSCIENCES INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NEUROCRINE BIOSCIENCES INC (NBIX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-31
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 4.80M shares, a 23.81% decline year-over-year.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.10M shares, a 24.24% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 3.30M shares, a 94.12% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 6.30M shares, a 173.91% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.00M shares, a 66.67% increase from fiscal 2024.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.40M shares, a 48.94% decline from fiscal 2023.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.70M shares.
- NEUROCRINE BIOSCIENCES INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 3.80M shares, a 7.32% decline from fiscal 2015.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 4.80M shares 10-Q · filed 2026-07-31 | 4.50M shares 10-Q · filed 2026-07-31 | |||
| 2026-03-31 | 4.10M shares 10-Q · filed 2026-05-05 | ||||
| 2025-12-31 | 4.00M shares 10-K · filed 2026-02-11 | ||||
| 2025-09-30 | 3.30M shares 10-Q · filed 2025-10-28 | 4.30M shares 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | 6.30M shares 10-Q · filed 2026-07-31 | 4.80M shares 10-Q · filed 2026-07-31 | |||
| 2025-03-31 | 3.30M shares 10-Q · filed 2026-05-05 | ||||
| 2024-12-31 | 2.40M shares 10-K · filed 2026-02-11 | ||||
| 2024-09-30 | 1.70M shares 10-Q · filed 2025-10-28 | 1.90M shares 10-Q · filed 2025-10-28 | |||
| 2024-06-30 | 2.30M shares 10-Q · filed 2025-07-30 | 2.00M shares 10-Q · filed 2025-07-30 | |||
| 2024-03-31 | 1.70M shares 10-Q · filed 2025-05-05 | ||||
| 2023-12-31 | 4.70M shares 10-K · filed 2026-02-11 | ||||
| 2023-09-30 | 4.40M shares 10-Q · filed 2024-10-30 | 5.20M shares 10-Q · filed 2024-10-30 | |||
| 2023-06-30 | 6.70M shares 10-Q · filed 2024-08-01 | 5.60M shares 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | 15.50M shares 10-Q · filed 2024-05-01 | ||||
| 2022-09-30 | 4.90M shares 10-Q · filed 2023-10-31 | 5.50M shares 10-Q · filed 2023-10-31 | |||
| 2022-06-30 | 12.50M shares 10-Q · filed 2023-08-01 | 12.20M shares 10-Q · filed 2023-08-01 | |||
| 2022-03-31 | 6.00M shares 10-Q · filed 2023-05-03 | ||||
| 2021-09-30 | 4.50M shares 10-Q · filed 2022-11-01 | 4.00M shares 10-Q · filed 2022-11-01 | |||
| 2021-06-30 | 4.70M shares 10-Q · filed 2022-08-04 | 3.70M shares 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | 2.70M shares 10-Q · filed 2022-05-04 | ||||
| 2020-09-30 | 10.90M shares 10-Q · filed 2021-11-01 | 2.30M shares 10-Q · filed 2021-11-01 | |||
| 2020-06-30 | 2.20M shares 10-Q · filed 2021-08-03 | 1.40M shares 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | 3.30M shares 10-Q · filed 2021-05-05 | ||||
| 2017-09-30 | 200.00K shares 10-Q · filed 2017-11-01 | 400.00K shares 10-Q · filed 2017-11-01 | |||
| 2017-06-30 | 400.00K shares 10-Q · filed 2017-08-03 | 500.00K shares 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | 1.40M shares 10-Q · filed 2017-05-09 | ||||
| 2016-12-31 | 3.80M shares 10-K · filed 2017-02-14 | ||||
| 2016-09-30 | 100.00K shares 10-Q · filed 2017-11-01 | 400.00K shares 10-Q · filed 2017-11-01 | |||
| 2016-06-30 | 300.00K shares 10-Q · filed 2017-08-03 | 300.00K shares 10-Q · filed 2017-08-03 | |||
| 2016-03-31 | 500.00K shares 10-Q · filed 2017-05-09 | ||||
| 2015-12-31 | 4.10M shares 10-K · filed 2017-02-14 | ||||
| 2015-09-30 | 100.00K shares 10-Q · filed 2016-11-02 | 300.00K shares 10-Q · filed 2016-11-02 | |||
| 2015-06-30 | 200.00K shares 10-Q · filed 2016-08-03 | 300.00K shares 10-Q · filed 2016-08-03 | |||
| 2015-03-31 | 100.00K shares 10-Q · filed 2016-05-05 | ||||
| 2014-12-31 | 2.90M shares 10-K · filed 2017-02-14 | 1.00M shares 10-K · filed 2015-02-09 | |||
| 2014-09-30 | 900.00K shares 10-Q · filed 2015-10-29 | 900.00K shares 10-Q · filed 2015-10-29 | |||
| 2014-06-30 | 900.00K shares 10-Q · filed 2015-07-29 | 900.00K shares 10-Q · filed 2015-07-29 | |||
| 2014-03-31 | 900.00K shares 10-Q · filed 2015-04-30 | ||||
| 2013-12-31 | 2.10M shares 10-K · filed 2016-02-11 | 300.00K shares 10-K · filed 2014-02-11 | |||
| 2013-09-30 | 100.00K shares 10-Q · filed 2014-11-04 | 300.00K shares 10-Q · filed 2014-11-04 | |||
| 2013-06-30 | 300.00K shares 10-Q · filed 2014-08-06 | 600.00K shares 10-Q · filed 2014-08-06 | |||
| 2013-03-31 | 800.00K shares 10-Q · filed 2014-05-01 | ||||
| 2012-12-31 | 2.20M shares 10-K · filed 2015-02-09 | ||||
| 2012-09-30 | 2.30M shares 10-Q · filed 2013-10-29 | 2.30M shares 10-Q · filed 2013-10-29 | |||
| 2012-06-30 | 2.40M shares 10-Q · filed 2013-07-26 | 2.30M shares 10-Q · filed 2013-07-26 | |||
| 2012-03-31 | 2.40M shares 10-Q · filed 2013-05-02 | ||||
| 2011-12-31 | 1.30M shares 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | 1.40M shares 10-Q · filed 2012-10-31 | 1.40M shares 10-Q · filed 2012-10-31 | |||
| 2011-06-30 | 1.30M shares 10-Q · filed 2012-07-31 | 1.30M shares 10-Q · filed 2012-07-31 | |||
| 2010-12-31 | 500.00K shares 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |